Evaluation of susceptibility testing methods for polymyxin

International Journal of Infectious Diseases

Volumn 14, Issue 7, 2010, Pages

  Behera, Bijayini ^a   Mathur, Purva ^a   Das, Anupam ^a   Kapil, Arti ^a   Gupta, Babita ^a   Bhoi, Sanjeev ^a   Farooque, Kamran ^a   Sharma, Vijay ^a   Misra, M C ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Agar dilution; Broth microdilution; Disk diffusion; E test; ICU; Polymyxin

Indexed keywords

COLISTIN; POLYMYXIN B; ANTIINFECTIVE AGENT;

ACINETOBACTER; AGAR DILUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; BROTH DILUTION; BURKHOLDERIA CEPACIA; CONTROLLED STUDY; DISK DIFFUSION; ENTEROBACTER; EPSILOMETER TEST; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; KLEBSIELLA; MORGANELLA MORGANII; NONHUMAN; PROTEUS MIRABILIS; PROVIDENCIA; PSEUDOMONAS AERUGINOSA; STENOTROPHOMONAS MALTOPHILIA; DRUG EFFECTS; EVALUATION STUDY; HUMAN; MICROBIAL SENSITIVITY TEST; PROCEDURES; STANDARDS;

ANTI-BACTERIAL AGENTS; COLISTIN; DISK DIFFUSION ANTIMICROBIAL TESTS; DRUG RESISTANCE, BACTERIAL; GRAM-NEGATIVE BACTERIA; HUMANS; MICROBIAL SENSITIVITY TESTS; POLYMYXIN B;

EID: 77953287391     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2009.09.001     Document Type: Article

References (22)

1. Falagas M.E., Kasiakou S.K., Tsiodras S., and Michalopoulos A. The use of intravenous and aerosolized polymyxins for the treatment of infections in critically ill patients: a review of the recent literature. Clin Med Res 4 (2006) 138-146
2. Arnold T.M., Forrest G.N., and Messmer K.J. Polymyxin antibiotics for Gram-negative infections. Am J Health Syst Pharm 64 (2007) 819-826
3. Falagas M.E., Bliziotis I.A., Kasiakou S.K., Samonis G., Athanassoupoulou P., and Michalopoulos A. Outcome of infections due to pandrug-resistant (PDR) Gram-negative bacteria. BMC Infect Dis 5 (2005) 24
4. Michalopoulos A.S., Tsiodras S., Rellos K., Mentzelopoulos S., and Falagas M.E. Colistin treatment in patients with ICU-acquired infections caused by multi-resistant Gram-negative bacteria: the renaissance of an old antibiotic. Clin Microbiol Infect 11 (2005) 115-121
5. Evans M.E., Feola D.J., and Rapp R.P. Polymyxin B sulfate and colistin: old antibiotics for emerging multi-resistant Gram-negative bacteria. Ann Pharmacother 33 (1999) 960-967
6. Levin A.S., Barone A.A., Penco J., Santos M.V., Marinho I.S., Manrique E.I., et al. Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Clin Infect Dis 28 (1999) 1008-1011
7. Littlewood J.M., Koch C., Lambert P.A., Hoiby N., Elborn J.S., Conway S.P., et al. A ten year review of colomycin. Respir Med 94 (2000) 63-71
8. Hogardt M., Schmoldt S., Gotzfried M., Adler K., and Hessemann J. Pitfalls of polymyxin antimicrobial susceptibility testing of Pseudomonas aeruginosa isolated from cystic fibrosis patients. J Antimicrob Chemother 54 (2004) 1057-1061
9. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Seventh informational supplement M100-S15. Wayne, PA: CLSI; 2005.
10. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Seventh informational supplement M100-S17. Wayne, PA: CLSI; 2007.
11. Collee J.G., Diguid J.P., and Fraser A.G. Mackie and McCartney practical medical microbiology. 14th ed. (1996), Churchill Livingstone, Edinburgh
12. th informational supplement M100-S16. Wayne, PA: CLSI; 2006.
13. th ed., M7-A6. Wayne, PA: CLSI; 2003.
14. Gales A.C., Jones R.N., and Sader H.S. Global assessment of the antimicrobial activity of polymyxin B against 54731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004). Clin Microbiol Infect 12 (2006) 315-321
15. Tan T.Y., and Ng S.Y. Comparison of E-test, Vitek and agar dilution for susceptibility testing of colistin. Clin Microbiol Infect 13 (2007) 541-544
16. th informational supplement. Vol. 29 (3). Wayne, PA: CLSI; 2009.
17. van der Heijden I.M., Levin A.S., De Pedri E.H., Fung L., Rossi F., Duboc G., et al. Comparison of disc diffusion, E-test and broth microdilution for testing susceptibility of carbapenem-resistant P. aeruginosa to polymyxins. Ann Clin Microbiol Antimicrob 6 (2007) 8
18. th ed. Wayne, PA: NCCLS; 2002.
19. National Committee for Clinical and Laboratory Standards. Development of in vitro susceptibility testing criteria and quality control parameters. Approved standard M23-A2. Wayne, PA: NCCLS; 1981.
20. Mathur P., Kapil A., Das B., and Dhawan B. Prevalence of extended spectrum beta lactamase producing Gram-negative bacteria in a tertiary care hospital. Indian J Med Res 115 (2002) 153-157
21. Behera B., Das A., Mathur P., and Kapil A. High prevalence of carbapenem resistant Pseudomonas aeruginosa at a tertiary care centre of India. Are we under reporting?. Ind J Med Res 128 (2008) 324-325
22. Arroyo L.A., Garcia-Curiel A., Pachon-lbanez M.E., Llnoas A.C., Ruiz M., Pachon J., et al. Reliability of the E-test method for detection of colistin resistance in clinical isolates of Acinetobacter baumannii. J Clin Microbiol 43 (2005) 903-905